Oracle announced Monday the purchase of Micros Systems for $5.3B, or $68 per share. Oracle plans to combine Micros' industry-specific applications with its own business software. Not only that, Oracle says the deal will immediately add to its adjusted earnings. Meanwhile, shares of Vertex Pharmaceuticals soared more than 40% Tuesday after the drugmaker said its cystic fibrosis treatment worked better than a placebo in a late-stage study. Cystic fibrosis is a rare inherited disease that causes thick mucus to form in the lungs. Finally, the Commerce Department gave Pioneer Natural Resources and Enterprise Products Partners permission to ship a type of ultralight oil to foreign buyers. The shipments will be America's first oil exports in nearly 40 years.

More from Video

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Will Tesla CEO Elon Musk Really Pulverize the Haters?

Will Tesla CEO Elon Musk Really Pulverize the Haters?

Jim Cramer's Investing Rule #4: Buy Damaged Stocks, Not Damaged Companies

Jim Cramer's Investing Rule #4: Buy Damaged Stocks, Not Damaged Companies

Jim Cramer's Investing Rule #3: Don't Buy Stocks All at Once

Jim Cramer's Investing Rule #3: Don't Buy Stocks All at Once